The U.S. Federal Trade Commission (FTC) has requested for more information from AbbVie Inc (ABBV.N) and botox maker Allergan Plc (AGN.N) on their $63 billion deal, the companies said on Friday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,